Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Tobery

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Antimicrobial Agents and Chemotherapy|December 28, 2007
Treatment of experimental anthrax with recombinant capsule depolymeraseAngelo Scorpio, Steven A Tobery, Wilson J Ribot, et al.
Immunohorizons|February 10, 2021
Poly-γ-Glutamic Acid Encapsulation of <i>Bacillus anthracis</i> Inhibits Human Dendritic Cell ResponsesTanya M Jelacic, Wilson J Ribot, Steven A Tobery, et al.
Infection and Immunity|July 21, 2022
Burkholderia pseudomallei JW270 Is Lethal in the Madagascar Hissing Cockroach Infection Model and Can Be Utilized at Biosafety Level 2 to Identify Putative Virulence FactorsJennifer Chua, Ethan Nguyenkhoa, Sherry Mou, et al.
Vaccine|November 3, 2004
Anthrax capsule vaccine protects against experimental infectionDonald J Chabot, Angelo Scorpio, Steven A Tobery, et al.
Plos Pathogens|September 29, 2022
The capsule of Bacillus anthracis protects it from the bactericidal activity of human defensins and other cationic antimicrobial peptidesDavid K O'Brien, Wilson J Ribot, Donald J Chabot, et al.
Infection and Immunity|June 4, 2014
Exposure to Bacillus anthracis capsule results in suppression of human monocyte-derived dendritic cellsTanya M Jelacic, Donald J Chabot, Joel A Bozue, et al.
The Journal of Infectious Diseases|December 23, 2008
A short course of antibiotic treatment is effective in preventing death from experimental inhalational anthrax after discontinuing antibioticsNicholas J Vietri, Bret K Purcell, Steven A Tobery, et al.
Emerging Infectious Diseases|January 26, 2019
Formaldehyde and Glutaraldehyde Inactivation of Bacterial Tier 1 Select Agents in TissuesJennifer Chua, Joel A Bozue, Christopher P Klimko, et al.
Microbial Pathogenesis|April 29, 2021
Comparison of three non-human primate aerosol models for glanders, caused by Burkholderia malleiDavid M Waag, Taylor B Chance, Sylvia R Trevino, et al.
The Journal of Infectious Diseases|July 23, 2020
Clindamycin Protects Nonhuman Primates Against Inhalational Anthrax But Does Not Enhance Reduction of Circulating Toxin Levels When Combined With CiprofloxacinNicholas J Vietri, Steven A Tobery, Donald J Chabot, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Antimicrobial Agents and Chemotherapy|December 28, 2007
Treatment of experimental anthrax with recombinant capsule depolymeraseAngelo Scorpio, Steven A Tobery, Wilson J Ribot, et al.
Immunohorizons|February 10, 2021
Poly-γ-Glutamic Acid Encapsulation of <i>Bacillus anthracis</i> Inhibits Human Dendritic Cell ResponsesTanya M Jelacic, Wilson J Ribot, Steven A Tobery, et al.
Infection and Immunity|July 21, 2022
Burkholderia pseudomallei JW270 Is Lethal in the Madagascar Hissing Cockroach Infection Model and Can Be Utilized at Biosafety Level 2 to Identify Putative Virulence FactorsJennifer Chua, Ethan Nguyenkhoa, Sherry Mou, et al.
Vaccine|November 3, 2004
Anthrax capsule vaccine protects against experimental infectionDonald J Chabot, Angelo Scorpio, Steven A Tobery, et al.
Plos Pathogens|September 29, 2022
The capsule of Bacillus anthracis protects it from the bactericidal activity of human defensins and other cationic antimicrobial peptidesDavid K O'Brien, Wilson J Ribot, Donald J Chabot, et al.
Infection and Immunity|June 4, 2014
Exposure to Bacillus anthracis capsule results in suppression of human monocyte-derived dendritic cellsTanya M Jelacic, Donald J Chabot, Joel A Bozue, et al.
The Journal of Infectious Diseases|December 23, 2008
A short course of antibiotic treatment is effective in preventing death from experimental inhalational anthrax after discontinuing antibioticsNicholas J Vietri, Bret K Purcell, Steven A Tobery, et al.
Emerging Infectious Diseases|January 26, 2019
Formaldehyde and Glutaraldehyde Inactivation of Bacterial Tier 1 Select Agents in TissuesJennifer Chua, Joel A Bozue, Christopher P Klimko, et al.
Microbial Pathogenesis|April 29, 2021
Comparison of three non-human primate aerosol models for glanders, caused by Burkholderia malleiDavid M Waag, Taylor B Chance, Sylvia R Trevino, et al.
The Journal of Infectious Diseases|July 23, 2020
Clindamycin Protects Nonhuman Primates Against Inhalational Anthrax But Does Not Enhance Reduction of Circulating Toxin Levels When Combined With CiprofloxacinNicholas J Vietri, Steven A Tobery, Donald J Chabot, et al.
Pageof 1